Member Info for gotabesirius

Two contracts due in the next month. Fact the company has gone quiet is a big plus imho. Busy busy.... Give the guys chance

https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.fiercebiotech.com/biotech/hvivo-preps-phase-3-for-universal-flu-vaccine&ved=2ahUKEwisgK-RwqfoAhVUfMAKHfRWARUQFjAEegQIAhAB&usg=AOvVaw2Ysy6jRa86fxHRzb5UjXbj&cshid=1584654918058

I agree.. But he holds purse strings of richest country on planet...

Company is in the Wall St Journal today so no better place for like of Trump's attention. Was only last week where he offered $1 billion to try and take out a German company. M&A in this sector is going to be rife... Imho...

No 950k buy, there was a 750k buy yesterday ater close as well ??

What's the bets someone in US is short here.... Volume kicks in. Midday.... Driving the price down...... Shorting should be banned

Two matched trades just above 5p weren't both sells. Probably an ISA transfer.... I think the seller has gone

Can you buy now? Looks like a big buy order being worked...

There's a hungry buyer around this morning as well!

Are you a shareholder?

Beauty with tech is it shouldn't be affected by current crisis!!

Anyone know how long this takes?

Take you positions for this RNS..... the end

https://www.kwm.com/en/uk

Check out the profile of this business!!

"Darren Roiser was appointed Managing Partner of the London office of King & Wood Mallesons – Asia’s number one law firm (estimated global revenue of USD 1billion), last year age 38."

"Darren's clients range from prestigious UK public schools, musicians, high-net-worth families and Scandinavian “green energy” start-ups to Russian oligarchs, Chinese tech giants and state-owned enterprises investing in key UK energy and infrastructure assets."

"The Company is in early discussions with King & Wood Mallesons, acting on behalf of selected Chinese pharmaceutical and life science clients, to secure funding for the further development of this Coronavirus challenge study. It is intended that the major cost of developing this Coronavirus human challenge model will be primarily funded by new Chinese pharmaceutical partner companies who will get a return on their investment from royalties on the sale of this particular challenge study model."

"The German government confirmed that Trump offered German scientists working on a coronavirus vaccine $1 billion for exclusive rights for the vaccine to be used “only in the U.S.A.” The German government viewed the attempt as a hostile takeover of their pharmaceutical industry."

This is just the start of the M&A activity around pharmaceutical companies that can help with a coronavirus cure! That coronavirus challenge study will be a biggy for Hvivo, once completed companied will be 'banging on the door' unless the door gets knocked in by a country wanting exclusive rights to test their vaccines...

And the Flu-v lottery ticket odds are getting shorter by the minute!

How the share price of this company hasn't gone up is beyond me!

It'll be bought out long before then... Just a matter of how much we get....

My theory is you always get legacy sellers from takeovers / mergers who look to use new found liquidity to exit. Its Cathal's job to find buyers for these destressed holders... This has churned away from quite some time now and any day now I expect it'll pop! Just like big pharmers did today. Sit back, relax and let watch this company revalue in Q2!!

brilliant link....

Highlights my point exactly. Suddenly everyone of power with money will be looking to secure assets and services and vaccines to protect their population. Should the UK government not step in and take flu v on...

£100m special dividend would be handy!

This is why I've moved a lot of money into here. Where else do you get such value or such opportunity with the current market turmoil....?